SCHEMBL2224579

SCHEMBL2224579

Cc1ccc(-c2nc3ccc(C)cn3c2CNc2cnccn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
HPGD P15428 2/20 0.52
ALDH1A1 P00352 1/20 0.52
NR1H4 Q96RI1 9/20 0.50
GABRA1 P14867 2/20 0.48
GABRB2 P47870 2/20 0.48
LMNA P02545 1/20 0.48
ALB P02768 1/20 0.48
CYP3A4 P08684 1/20 0.48
CHRM1 P11229 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA3 P34903 1/20 0.48
ADRA1A P35348 1/20 0.48
OPRK1 P41145 1/20 0.48
HTR2B P41595 1/20 0.48
GABRA2 P47869 1/20 0.48
KCNH2 Q12809 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2229533 0.85 NR1H4 (0.55) KDM4EHPGDNR1H4GABRA1GABRB2
SCHEMBL2221209 0.82 NR1H4 (0.56) KDM4EHPGDNR1H4GABRA1GABRB2
SCHEMBL1431018 0.81 NR1H4 (0.50) KDM4EHPGDNR1H4GABRA1GABRB2
SCHEMBL1430399 0.81 NR1H4 (0.52) KDM4EHPGDNR1H4GABRA1GABRB2
SCHEMBL2229637 0.81 NR1H4 (0.52) KDM4EHPGDALDH1A1NR1H4GABRA1
SCHEMBL8267113 0.80 SMN1; SMN2 (0.57) KDM4EHPGDNR1H4GABRA1GABRB2
SCHEMBL2224848 0.79 NR1H4 (0.52) KDM4EHPGDNR1H4GABRA1GABRB2
SCHEMBL1432386 0.79 NR1H4 (0.50) KDM4EHPGDNR1H4GABRA1GABRB2
SCHEMBL2223094 0.78 NR1H4 (0.49) KDM4EHPGDNR1H4GABRA1GABRB2
SCHEMBL2226993 0.78 NR1H4 (0.49) KDM4EHPGDNR1H4GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. 2013-10-31 US disclosed
US-8497278-B2 Imidazo[1,2-a]pyridine compounds SUNOVION PHARMACEUTICALS INC. (US) 2013-07-30 US disclosed
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD KDM4E 3088/4885HPGD 299/4885ALDH1A1 269/4885
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD KDM4E 3088/4885HPGD 299/4885ALDH1A1 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.